← Back to Search

Deep Brain Stimulation and Decision-Making Tasks for Parkinson's Disease (MPPN Trial)

N/A

Recruiting

Led By Simon J Little, MBBS, PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years

Awards & highlights

MPPN Trial Summary

This trial will help researchers learn more about how Parkinson's patients make decisions, in hopes of improving treatments for the disease.

Who is the study for?

This trial is for Parkinson's patients who already have a Medtronic Percept PC DBS device implanted. It's not suitable for those with severe cognitive impairments.Check my eligibility

What is being tested?

The study examines how deep brain stimulation (DBS) affects motivation and decision-making in Parkinson's patients, using tasks with the stimulation turned on and off.See study design

What are the potential side effects?

While this study isn't testing a drug, side effects may include discomfort or changes in mood or behavior due to varying levels of brain stimulation during the tasks.

MPPN Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years

This trial's timeline: 3 weeks for screening, Varies for treatment, and the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of Risky Decisions made with Percept PC DBS stimulation off for Parkinson's Disease Patients

Parkinson Disease

MPPN Trial Design

2Treatment groups

Experimental Treatment

Group I: StimulationExperimental Treatment2 Interventions

Patients will be getting standard clinically acceptable stimulation within already safety validated stimulation ranges through their Medtronic Percept PC device.

Group II: No StimulationExperimental Treatment2 Interventions

Patients will have stimulation turned off through their Medtronic Percept PC device.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,505 Previous Clinical Trials

15,237,535 Total Patients Enrolled

Yale UniversityOTHER

1,848 Previous Clinical Trials

2,737,798 Total Patients Enrolled

Rune LabsUNKNOWN

Media Library

Stimulation on Clinical Trial Eligibility Overview. Trial Name: NCT05065151 — N/A

Deep Brain Stimulation Research Study Groups: No Stimulation, Stimulation

Deep Brain Stimulation Clinical Trial 2023: Stimulation on Highlights & Side Effects. Trial Name: NCT05065151 — N/A

Stimulation on 2023 Treatment Timeline for Medical Study. Trial Name: NCT05065151 — N/A

Deep Brain Stimulation Patient Testimony for trial: Trial Name: NCT05065151 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this study currently available to participants?

"As per the information collated on clinicaltrials.gov this investigation is actively seeking volunteers. This trial was initially posted on October 30th 2021, and its data was most recently updated on March 21st 2022."

Answered by AI

How many volunteers are participating in this experiment?

"Affirmative. Clinicaltrials.gov attests that this medical experiment, which was published on October 30th 2021, is actively seeking participants. Twenty individuals must be recruited from a single trial site to complete the study."

Answered by AI